74 related articles for article (PubMed ID: 10521690)
41. Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements.
Nichols AF; Itoh T; Zolezzi F; Hutsell S; Linn S
Nucleic Acids Res; 2003 Jan; 31(2):562-9. PubMed ID: 12527763
[TBL] [Abstract][Full Text] [Related]
42. Binding of the transcription factor, Sp1, to non-target sites in DNA modified by benzo[a]pyrene diol epoxide.
MacLeod MC; Powell KL; Tran N
Carcinogenesis; 1995 May; 16(5):975-83. PubMed ID: 7767996
[TBL] [Abstract][Full Text] [Related]
43. Cyclic adenosine monophosphate (cAMP) stimulation of the kit ligand promoter in sertoli cells requires an Sp1-binding region, a canonical TATA box, and a cAMP-induced factor binding to an immediately downstream GC-rich element.
Grimaldi P; Capolunghi F; Geremia R; Rossi P
Biol Reprod; 2003 Dec; 69(6):1979-88. PubMed ID: 12904318
[TBL] [Abstract][Full Text] [Related]
44. Molecular characterization of the constitutive expression of the plasma platelet-activating factor acetylhydrolase gene in macrophages.
Wu X; McIntyre TM; Zimmerman GA; Prescott SM; Stafforini DM
Biochem J; 2003 Oct; 375(Pt 2):351-63. PubMed ID: 12854969
[TBL] [Abstract][Full Text] [Related]
45. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
[TBL] [Abstract][Full Text] [Related]
46. NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells.
Lin CJ; Martens JW; Miller WL
Mol Endocrinol; 2001 Aug; 15(8):1277-93. PubMed ID: 11463853
[TBL] [Abstract][Full Text] [Related]
47. Activator protein-2 mediates transcriptional activation of the CYP11A1 gene by interaction with Sp1 rather than binding to DNA.
Pena P; Reutens AT; Albanese C; D'Amico M; Watanabe G; Donner A; Shu IW; Williams T; Pestell RG
Mol Endocrinol; 1999 Aug; 13(8):1402-16. PubMed ID: 10446912
[TBL] [Abstract][Full Text] [Related]
48. Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
Aoki K; Kato J; Shoemaker MT; Moss J
Gene; 2005 May; 351():83-95. PubMed ID: 15893437
[TBL] [Abstract][Full Text] [Related]
49. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
Zelko IN; Folz RJ
Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
[TBL] [Abstract][Full Text] [Related]
50. Heterogeneity of nitrogen mustard-induced DNA damage and repair at the level of the gene in Chinese hamster ovary cells.
Wassermann K; Kohn KW; Bohr VA
J Biol Chem; 1990 Aug; 265(23):13906-13. PubMed ID: 2380193
[TBL] [Abstract][Full Text] [Related]
51. Decreased stability of DNA in cells treated with alkylating agents.
Frankfurt OS
Exp Cell Res; 1990 Dec; 191(2):181-5. PubMed ID: 2257876
[TBL] [Abstract][Full Text] [Related]
52. Effects of alkylation by dimethyl sulfate, nitrogen mustard, and mitomycin C on DNA structure as studied by the ethidium binding assay.
Hsiung H; Lown JW
Can J Biochem; 1976 Dec; 54(12):1047-54. PubMed ID: 13915
[TBL] [Abstract][Full Text] [Related]
53. Immobilization of DNA on Biosensing Devices with Nitrogen Mustard-Modified Linkers.
Kurinomaru T; Kojima N; Kurita R
Curr Protoc Nucleic Acid Chem; 2019 Jun; 77(1):e85. PubMed ID: 31038292
[TBL] [Abstract][Full Text] [Related]
54. Supramolecular detoxification of nitrogen mustard
Zhou S; Chen Y; Xu J; Yin Y; Yu J; Liu W; Chen S; Wang L
J Mater Chem B; 2023 Mar; 11(12):2706-2713. PubMed ID: 36876404
[TBL] [Abstract][Full Text] [Related]
55. The copper-containing monocarboranylporphyrin: a prototype of new DNA-binding cytotoxic compounds.
Shishkin AA; Ivanov OG; Zaitsev AV; Kononova EG; Malinina EA; Ol'shevskaya VA; Kalinin VN; Hofmann J; Shtil AA
Dokl Biochem Biophys; 2005; 403():313-6. PubMed ID: 16229151
[No Abstract] [Full Text] [Related]
56. Therapeutic Agents Based on DNA Sequence Specific Binding.
Pett L; Hartley JA; Kiakos K
Curr Top Med Chem; 2015; 15(14):1293-322. PubMed ID: 25866278
[TBL] [Abstract][Full Text] [Related]
57. Evidence for the inactivation and repair of the mammalian DNA template after alkylation by mustard gas and half mustard gas.
Roberts JJ; Brent TP; Crathorn AR
Eur J Cancer (1965); 1971 Dec; 7(6):515-24. PubMed ID: 5143809
[No Abstract] [Full Text] [Related]
58. Development and validation of a PCR-based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs.
Stefanou DT; Episkopou H; Kyrtopoulos SA; Bamias A; Gkotzamanidou M; Bamia C; Liakou C; Bekyrou M; Sfikakis PP; Dimopoulos MA; Souliotis VL
Br J Clin Pharmacol; 2012 Nov; 74(5):842-53. PubMed ID: 22432918
[TBL] [Abstract][Full Text] [Related]
59. Quantitative PCR analysis of diepoxybutane and epihalohydrin damage to nuclear versus mitochondrial DNA.
Lariviere FJ; Newman AG; Watts ML; Bradley SQ; Juskewitch JE; Greenwood PG; Millard JT
Mutat Res; 2009 May; 664(1-2):48-54. PubMed ID: 19428380
[TBL] [Abstract][Full Text] [Related]
60. DNA damage by nitrogen mustard in a gene containing multiple Sp1-binding sites.
Chen X; Cullinane C; Gray PJ; Phillips DR
Mutat Res; 1999 Sep; 445(1):45-54. PubMed ID: 10521690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]